小肠罕见疾病的内镜治疗研究

Endoscopic Treatment of Rare Small Intestinal Diseases

  • 摘要:
    目的 探究小肠镜在治疗黑斑息肉综合征(Peutz-Jeghers syndrome,PJS)、蓝色橡皮疱样痣综合征(blue rubber bleb nevus syndrome,BRBNS)、隐源性多灶性溃疡性狭窄性肠炎(cryptogenic multifocal ulcerative stenosing enteritis,CMUSE)等小肠罕见疾病中的安全性与有效性,为临床诊疗提供参考依据。
    方法 纳入2020年1月至2024年12月在上海长海医院消化内科诊治的小肠罕见病患者,详细记录患者一般情况、临床表现、辅助检查、内镜治疗信息等,并进行系统分析。
    结果 共纳入30例PJS患者,行88次小肠镜息肉切除术,其中经口入径62次,操作时间为(92.8±30.1)min,最大息肉直径为(2.9±1.2) cm;经肛入径则分别为26次、(95.0±29.4)min和(1.9±1.3)cm。经口入径发生6例不良事件。10例BRBNS患者行26次治疗(硬化剂注射25次,联合套扎1次),操作时间(68.1±17.4)min,套扎静脉瘤11个,不良事件4例。5例CMUSE患者行6次治疗(球囊扩张5次,狭窄切开1次),无不良事件。
    结论 小肠镜下治疗PJS、BRBNS和CMUSE等小肠罕见疾病可行,具有一定的安全性和有效性。对于PJS患者行小肠镜治疗时,应优先选择经口入径。BRBNS采用小肠镜下小肠静脉瘤硬化剂注射术安全有效,但小肠镜下静脉瘤套扎术的安全性有待进一步深入研究。CMUSE采用小肠镜下小肠狭窄球囊扩张术和小肠狭窄切开术均可行,且两种方法可相互补充。

     

    Abstract:
    Objective To evaluate the safety and efficacy of enteroscopy in the treatment of rare small intestinal diseases, including Peutz-Jeghers syndrome (PJS), blue rubber bleb nevus syndrome(BRBNS), and cryptogenic multifocal ulcerative stenosing enteritis (CMUSE), thereby providing a reference for clinical diagnosis and treatment.
    Methods Patients with rare small intestinal diseases diagnosed and treated in the Department of Gastroenterology, Shanghai Changhai Hospital, from January 2020 to December 2024 were included. Detailed records of patients′ general information, clinical manifestations, auxiliary examinations, and endoscopic treatment data were collected and systematically analyzed.
    Results A total of 30 PJS patients underwent 88 small intestinalpolypectomies under enteroscopy, including 62 procedures via the oral approach (mean operative time: 92.8±30.1 min; largest polyp diameter: 2.9±1.2 cm) and 26 via the anal approach (95.0±29.4 min; 1.9±1.3 cm). Six adverse events occurred in the oral approach group. Ten BRBNS patients received 26 endoscopic treatments (25 sclerosing agent injection under enteroscopy and 1 sclerosing agent injection combined with ligation session), with a mean operative time of 68.1±17.4 min. Eleven intestinal venous aneurysms were ligated, and 4 adverse events were reported. Five CMUSE patients underwent 6 endoscopic treatments (5 samll intestinal stenosis balloon dilations and 1 samll intestinal stenosis incision), with no adverse events observed.
    Conclusions Small intestinal endoscopy is feasible, safe, and effective for treating rare small intestinal diseases such as PJS, BRBNS, and CMUSE. For PJS patients, the oral approach should be prioritized. Sclerosing agent injection under enteroscopy for intestinal venous aneurysms in BRBNS via small bowel endoscopy is safe and effective, though the safety of ligation of venous aneurysms under enteroscopy requires further investigation. Stenosis balloon dilation and incision under enteroscopy are both feasible options for CMUSE, and these two approaches can complement each other.

     

/

返回文章
返回